Fit-for-Purpose COA Development: 25 years developing, modifying and validating PROs in more than 60 therapeutic categories. LEARN MORE

QualityMetric is now an IQVIA Business: click here for more information on the IQVIA COAs available for licensing

Translation Services: 25 years developing linguistically validated translations of COAs, CRFs, protocols, manuals, etc… READ MORE

QualityMetric By The Numbers: 53,000,000+ Global Survey administrations, 48,000+ Peer-reviewed articles across 100+ conditions, 200+ Language translations by mode of administrations, 100+ Condition-Specific, Country-Specific, and Insurance Claims Benchmarks General Population Norms. Which survey should you use? SEE OUR SUITE OF PRO SURVEYS

ePRO & EDC Integration: Seamless integration for optimal efficiencies using Web Service Application Programming Interface (API), Single Sign-on Access (SSO) or Electronic-Friendly Survey Administration. FIND OUT HOW

HIT-6 NEW PROS IN ONCOLOGY GUIDE

QM PROs can help capture slowed decline in physical functioning and well-being. Learn how to illuminate the impact of cancer treatments and therapies using PRO measures in a free oncology-focused guide.

Read the Guide

News

09.14.23

QualityMetric Presentations During ISOQOL 2023 Conference

 

Join the QualityMetric science team for several exciting presentations at the 30th Annual ISOQOL Conference in Calgary, Alberta, Canada, from October 18th through the 21st.

This year’s conference theme, Quality of Life, focuses on identifying and overcoming the barriers that limit the use of patient-reported outcomes (PROs) in everyday patient care. QualityMetric’s scientists are well-versed in this area of our work and aim to share best practices, tips and more in their presentations throughout ISOQOL 2023. We hope to see you at one of the following sessions!

Verifying the accuracy of programmed electronic patient-reported outcome (PRO) measures is vital to protect data quality

Lauren Henning, Sloan Rucker, Jahshaun Jenkins, Michelle Carty

Poster Session I

Date: Thursday 10/19

Poster Session Time: 10:05 a.m. MDT

View Poster

 

Meaningful within-patient change in patient-reported health status: Comparison of FDA guidance and approved label claims

Avery A. Rizio, Emily Chicklis, Mark Kosinski

Poster Session I

Date: Friday 10/20

Poster Session Time: 9:35 a.m. MDT

View Poster

 

Adaptation of the self-report SF-36v2® and SF-12v2® to proxy-reported outcome measures

Selected as one of the 2023 New Investigator Poster Presentation Award Finalists!

KD Jacobs, Jamie Pomeranz, Michelle Carty

Poster Session I

Date: Friday 10/20

Poster Session Time: 9:35 a.m. MDT

Get Instrument Details: SF-36v2®, SF-12v2®

View Poster

 

PRO measure standards for a Primary Cancer Survivor Care Clinic

John Librett, Mark Kosinski

Poster Session II

Date: Friday, 10/20

Poster Session Time: 2:55 p.m. MDT

View Poster

 

 

Best Practices for Clinical Outcome Assessment (COA) Concept Mapping: A Case Study Using the SF-36v2®

Meaghan O’Connor, Lynne Broderick, Miranda Lauher-Charest, Laura Tesler Waldman, Mark Kosinski, Michelle Carty, Kristi Jackson

Oral session 303: Methodology in Musculoskeletal Disorders

Date: Saturday 10/21

Oral Session Time: 10:15 a.m. MDT

Get Instrument Details: SF-36v2®

 

Interested in learning more about what QM can do for you?

Contact us today: [email protected] | (800) 572-9394

 

ISOQOL 2023

The International Society for Quality of Life Research (ISOQOL) is a global community of researchers, clinicians, health care professionals, industry professionals, consultants, and patient research partners advancing health related quality of life research (HRQL). Together, we are creating a future in which patient perspective is integral to health research, care and policy.